Background and Purpose-Acute ischemic stroke patients who receive recombinant tissue plasminogen activator (rt-PA) within 3 hours of symptom onset are 30% more likely to have minimal to no disability at 3 months. During hospitalization, short-term disability is subjectively measured by discharge disposition, whether to home, inpatient rehabilitation, a skilled nursing facility, or subacute care. There are no studies assessing the role of recombinant tissue plasminogen activator use as a predictor of poststroke discharge disposition. Methods-We conducted a retrospective analysis of all patients with ischemic stroke who presented within the original three hour window for intravenous thrombolysis, and who were admitted to the University of Texas Houston Medical
C erebrovascular disease is the leading cause of long-term disability in the United States, increasing costs of postacute care and caregiver burden. 1, 2 Outcomes research is critically important in this population, particularly related to poststroke discharge disposition. The discharge level of care after an acute stroke is directly related to clinical outcomes, including functional status, activity tolerance, and medical acuity.
Rehabilitation medicine is a relatively young and diverse field that extends from the first days of inpatient care to years of chronic treatment in a range of settings. 3 The goal of stroke rehabilitation is to improve recovery in the weeks after a stroke and to decrease disability during the years that follow. For an inpatient rehabilitation facility (IRF) to be compensated by Medicare, a minimum of 60% of the facility's total inpatient population must meet 1 of 13 medical conditions. The 13 medical conditions that qualify for the 60% rule are stroke, spinal cord injury, congenital deformity, amputation, major multiple trauma, brain injury, fracture of femur (hip), burns and neurological disorders, including multiple sclerosis, motor neuron diseases, polyneuropathy, muscular dystrophy, and Parkinson disease. 4 An incarnation of the compliance rule has been part of the IRF payment criteria since the implementation of the Inpatient Prospective Payment System in 1983. Its purpose is to ensure that IRFs are primarily providing rehabilitation services to patients who cannot be served in other, less intensive rehabilitation settings such as a skilled nursing facility (SNF). Over the past 10 years, this rule has undergone significant alterations. In 2002, the Center for Medicare and Medicaid Services instructed the Fiscal Intermediaries to delay enforcement of the 75% rule because of concerns that the criteria were not enforced uniformly across the country. 5 In 2004, the Center for Medicare and Medicaid Services reinstated the rule and expanded the compliance list to the 13 qualifying conditions. In addition, a 3-year transition period was instituted to gradually increase the compliance rate from 50% in 2004% to 75% by 2007. However, in 2007, Congress passed the Medicare, Medicaid, and SCHIP Extension Act, which set the IRF compliance rule at no more than 60% retroactive to cost-reporting periods beginning on or after July 1st. The influence of the compliance rule has been a longstanding source of concern for rehabilitation units, as Medicare accounts for approximately 70% of IRF cases with an estimated 5.6 billion dollars paid to IRFs annually. 6 To qualify for admission to an IRF, patients must require close medical supervision by a rehabilitation physician, 24-hour nursing care, and a coordinated multidisciplinary rehabilitation program consisting of a combination of physical therapy, occupational therapy, speech and language pathology, nursing, case management, and social work. In addition, patients must be able to participate in an intense rehabilitation regimen for a duration of a minimum of 3 hours daily and be expected to achieve significant practical improvement over a short period of time. 4 Patients receiving care in a SNF traditionally exhibit decreased activity tolerance; therefore, they would not be able to participate in 3 hours of therapy daily required for inpatient rehabilitation. A patient whose SNF stay is based solely on the need for rehabilitation services would meet the "daily basis" requirement, they would receive a combination of physical, occupational, and speech therapy at least 5 days a week. 7 Subacute care is a transitional level of treatment for medically stable patients who no longer require daily diagnostic/invasive care. Also known as long-term acute care, the patients at this level require 24-hour access to services available in an acute care hospital. In addition, the patient may require tracheotomy care and/or mechanical ventilation plus any 1 of 6 treatment procedures, including tube feeding, wound care, continuous intravenous therapy (hydration or antibiotic), frequent nebulizer treatments, total parental nutrition, and inpatient physical, occupational, or speech therapy. 8 Patients with stroke admitted to subacute care predominantly have severe disability due to large infarcts.
Intermediate care facilities provide treatment for individuals who are disabled, mentally handicapped, or chronically ill. 9 To qualify for intermediate care services, a patient must have a medical condition that requires observation on an intermittent basis to prevent deterioration. Compared with the previously mentioned levels of care, neither skilled nursing nor therapy services are required in intermediate care facilities. Patients in intermediate care facilities also exhibit more independence with basic activities of daily living than those served by inpatient rehabilitation, SNFs, or subacute care.
The National Institute of Neurological Disorders and Stroke rtPA Stroke Study investigators have demonstrated that patients with acute ischemic stroke receiving intravenous tissue plasminogen activator within 3 hours of symptom onset are 30% more likely to have minimal or no disability at 3 months. 10 During hospitalization, short-term disability and functional status are subjectively measured by discharge disposition, whether to home, inpatient rehabilitation (IR), a SNF, or subacute care (Sub). There are no studies assessing the role of recombinant intravenous tissue plasminogen activator (rtPA) treatment for acute ischemic stroke as a predictor of functional status evidenced by poststroke discharge disposition.
Subjects and Methods
We conducted a retrospective analysis a prospectively collected quality assured database of all patients with ischemic stroke admitted to the University of Texas Houston Medical School Stroke Service at Memorial Hermann Hospital Texas Medical Center between January 2004 and October 2009 with discharge disposition of home, IR, a SNF, or Sub. Memorial Hermann Hospital Texas Medical Center is a tertiary care center with an in-hospital inpatient rehabilitation unit; all patients who meet admission criteria are accepted, regardless of insurance type or ability to pay. Patients were included if they presented within the original 3-hour window for intravenous thrombolysis.
Baseline demographics, including age, gender, ethnicity, and National Institutes of Health Stroke Scale (NIHSS) score on arrival, were collected (Table 1 ). All patients had frequent vital sign monitoring including an electrocardiogram and 24 hours of telemetry. Cardiac and cerebrovascular imaging, lipid and glucose levels were obtained as part of routine practice; all of which were used in the multivariate model for risk stratification (Table 2) . Medical records were reviewed to determine presence of comorbidities that can affect outcome. Modified Rankin Scale score was obtained at discharge for all patients.
Exclusion criteria were diagnosis of intracranial hemorrhage, transient ischemic attack, and alternate disposition (discharge to other service or left against medical advice). Discharge to home for custodial/hospice care and death were included in the analysis to determine whether there was increased morbidity or mortality in the rtPA versus the non-rtPA group. Cerebrovascular disease risk factors were used for risk assessment and stratification; the presence of multiple medical comorbidities increase the likelihood of poststroke Table 3 ). The primary independent variable is the use of rtPA in acute ischemic stroke; the primary dependent variable is functional status. We used discharge disposition as a proxy for functional status. The levels of discharge disposition were matched in paired groupings (Home vs. Other Level of Care, Inpatient Rehabilitation vs. Skilled Nursing Facility or Subacute Care and Skilled Nursing Facility vs. Subacute Care). The NIHSS is an excellent predictor of clinical outcomes and hospital discharge disposition. 11, 12 We used NIHSS on arrival as a continuous variable in the multivariate regression; low NIHSS in patients with acute ischemic stroke predicts post stroke disposition to a level of care suggestive of improved functional status.
Statistical Analyses were performed using SAS 9.2 (Cary, NC). Continuous variables were reported as meanϮSD when the distribution was normal and median with range for nonnormal distributions. The NIHSS score was reported as the median with the interquartile range. Categorical variables were analyzed using 2 and Fisher exact tests when appropriate. We performed t test to assess the differences in means; Wilcoxon test was used to evaluate for differences in medians. We used logistic regression to determine differences in post-stroke disposition adjusting for cerebrovascular disease risk factors among patients who received rtPA for acute ischemic stroke.
Results
Out of our study sample size of 2459 patients with discharge disposition to home, inpatient rehabilitation, skilled nursing facility or subacute care, nine percent of the patients were excluded secondary to missing data for the explanatory variable (Table 1 ). This has been attributed to the merging of data fields from earlier forms of the University of Texas Houston Medical School Stroke Registry, a common quandary with outcomes studies. During secondary analysis, we discovered the missing fields were evenly distributed uniformly between primary independent and dependent variables. The administration of IV rt-PA for acute ischemic stroke is correlated with increased mortality (12% vs. 5.4% in the no rt-PA group; P ϭ Ͻ0.0001; Table 1 ); there were no statistically significant differences in the likelihood of discharge to home for hospice care (2.5% vs. 4% in the no rt-PA group; P ϭ 0.1638; Table 1 ). A total of 2756 patients were included in the independent risk stratification analyses (Tables 2 and 3) ; this was narrowed by 0.65% during assessment of demographic information due to missing variables for ethnicity.
Discharge Disposition to Home Versus Other Level of Care (IR, SNF, or Sub)
Of the remaining 2225 patients, 1019 were discharged home, 1206 to IR, a SNF, or Sub. After accounting for all effects in the multivariate regression, patients who received rtPA for acute ischemic stroke were more likely to be discharged home (PϽ0.0001; OR, 1.945; 95% CI, 1.538 to 2.459; Table  4 ). Both increased age (PϽ0.0001; OR, 0.967; 95% CI, 0.960 to 0.974) and NIHSS on arrival (PϽ0.0001; OR, 0.822; 95% CI, 0.805 to 0.840) were associated with discharge disposition to another level of care.
The odds ratio was higher for acute ischemic stroke patients treated with IV rt-PA in relation to discharge disposition than several cerebrovascular disease risk factors, including cardiovascular disease (Pϭ0.187; OR, 1.156; 95% CI, 0.932 to 1.434), diabetes mellitus (Pϭ0.041; OR, 0.803; 95% CI, 0.650 to 0.991), hypertension (Pϭ0.177; OR, 0.850; 95% CI, 0.671 to 1.076), hyperlipidemia (Pϭ0.016; OR, 0.774; 95% CI, 0.628 to 0.954), and history of stroke (Pϭ0.023; OR, 1.311; 95% CI, 1.037 to 1.658).
Discharge Disposition to IR Versus Other Level of Care (SNF or Sub)
Of the remaining 1206 patients with acute ischemic stroke, 719 patients were discharged to acute IR and 487 to either a SNF or Sub. After accounting for all effects in the multivariate regression, there were no statistically significant differences in disposition between patients who received and did not receive rtPA (Pϭ0.123; OR, 1.255; 95% CI, 0.940 to 1.675; Table 5 ). The presence of advanced age predicted discharge to a SNF or subacute level of care (PϽ0.0001; OR, 0.948; 95% CI, 0.938 to 0.958). Unlike the first analysis, cardiovascular disease predicted discharge to a SNF or Sub, which corroborates the importance of activity tolerance when determining poststroke discharge disposition (Pϭ0.031; OR, 0.741; 95% CI, 0.564 to 0.973).
Increased NIHSS on arrival predicts discharge disposition to a SNF or Sub independent of rtPA use (PϽ0.0001; OR, 0.913; 95% CI, 0.896 to 0.930). History of stroke is also predictive of discharge disposition to either a SNF or Sub; these patients are more likely to have a physical impairment at baseline (PϽ0.0001; OR, 2.424; 95% CI, 1.784 to 3.293). There were no significant differences in disposition to IR versus a SNF or Sub for patients with diabetes mellitus, hypertension, or hyperlipidemia (Table 5) .
Discharge Disposition to a SNF Versus Sub
Of the remaining 487 patients with acute ischemic stroke, 371 were discharged to a SNF and 116 to Sub. After accounting for all effects in the multivariate regression, there were no significant differences in disposition between patients who received rtPA for acute ischemic stroke (Pϭ0.605; OR, 0.884; 95% CI, 0.554 to 1.410; Table 6 ). Advanced age is predictive but not as strongly associated with discharge disposition to subacute care (Pϭ0.006; OR, 1.026; 95% CI, 1.007 to 1.045). It is known that patients with larger infarcts are more likely to be discharged to Sub than a SNF due to the severity of their deficits; in addition, there is significantly higher mortality of older patients in this group compared with the previous analyses.
Increased NIHSS on arrival (PϽ0.0001; OR, 0.945; 95% CI, 0.919 to 0.971) and history of stroke (PϽ0.0001; OR, 0.277; 95% CI, 0.153 to 0.501) both predict discharge disposition to Sub independent of rtPA use. There were no significant differences in disposition for patients with cardiovascular disease, diabetes mellitus, hypertension, or hyperlipidemia (Table 6 ).
Discussion
To our knowledge, this study is the first to provide a direct link between the administration of intravenous rtPA for treatment of patients with acute ischemic stroke and improved short-term outcomes evidenced by discharge disposition to home versus another level of care. The association between this short-term outcome and long-term disability has not been studied; this will be the focus of future research. Patients who received rt-PA tended to have higher NIHSS on arrival than the non-treatment group, lower age, normal cholesterol values and no prior history of stroke.
The variability of the 60% rule during the study time period has a potential confounding effect on patients admitted to IRFs. Although Congress passed the Medicare, Medicaid, and SCHIP Extension Act in 2007, it only applied to reimbursement of payments to IRFs; it has no bearing on our analyses and the appropriateness of the discharge level of care during that time period. Future studies will further be impacted by the new Center for Medicare and Medicaid Services 2010 IRF coverage requirements. The Center for Medicare and Medicaid Services 2010 guidelines are an effort to determine whether individual IRF claims are reasonable and necessary. The new coverage requirements document whether the patient is medically stable to benefit from IR admission, specify the need for coordinated multidisciplinary rehabilitation care, and outline benefit from the intensity of treatment provided in an IRF. 13 The impact of these new guidelines on IR admissions is yet to be seen, and it will be the subject of future studies.
Consistent with previous studies, we found that low NIHSS on arrival has the strongest correlation with discharge to home; however, the conclusion that rtPA use has a stronger correlation to favorable discharge disposition than several cerebrovascular disease risk factors has a significant impact on the role of rtPA as a prognostic indicator in this population. Our analysis is based on data collected within the traditional 3-hour window of intravenous thrombolysis; future studies will extrapolate the data to 4.5 hours.
There are considerable barriers to care in the IR, SNF, and Sub groups. Although organized stroke care with timely multidisciplinary IR is associated with improved outcomes, many patients are unable to access postacute rehabilitation services secondary to lack of insurance or underinsurance. Use and accessibility of postacute services vary with age, race/ethnicity, and geographic region. 14 Advanced age can be used as both an outcome predictor and a screening tool for Medicare eligibility in populations that may otherwise be uninsured. 8 Postacute care facilities predominantly serve patients who have the financial means to pay for care, whether through insurance or independently. This study was conducted at a tertiary care center with an in-hospital IRF; therefore, all patients who meet criteria for admission are accepted. The results of this study may not be extrapolated to centers in which patients have to undergo financial screening as a part of eligibility.
Disposition after postacute hospitalization is a factor in admission to each prospective level of care. If a candidate is IR-appropriate but needs supervision for safety, cognitive impairment, or physical limitations, it is recommended that a caregiver be identified before transfer of care is completed. These patients may be transferred to a SNF, which traditionally has a longer length of stay, until a caregiver becomes available. It is estimated that 25% to 74% of stroke survivors require assistance with activities of daily living from informal caregivers, often family members. 15 Although the physical, psychological, emotional, and social consequences of caregiving and its economic benefit to society are well recognized, caregivers' needs are often given low priority in stroke management and many caregivers feel inadequately trained, poorly informed, and dissatisfied with the level of support provided after discharge. 16 A key determinant of whether a patient can be discharged to home is the competency and physical ability of the caregiver, which is unrelated to the status of the patient. These patients may be appropriate for discharge home, but are instead admitted to an IRF or a SNF if their caregiver is unable to meet their functional needs.
We cannot comment on patients with ischemic stroke who transition to another level of care after IR. There is a percentage of patients who were determined to be appropriate for IR that are unable to tolerate 3 hours of therapy daily; therefore, they are transferred to a SNF. In the future, we will track the disposition of patients with acute stroke after IR to capture these outliers.
This analysis is retrospective; we endeavored to stratify the data for age, stroke severity, and known risk factors that suggest worse outcomes. In addition, the use of retrospective data makes it difficult to collect missing variables, which accounted for 9% loss of data in this study. There is potential confounding related to whether intravenous rtPA truly predicts better outcomes or are there other unknown causes. This possibility is best addressed with a prospective observational study of this patient group.
In summary, patients with acute ischemic stroke who received intravenous rtPA within the traditional 3-hour window were more likely to be discharged home and not require postacute hospitalization. Improvements in treatment of acute stroke frequently bring net health expenditure savings by reducing rehabilitation, postacute care, and lost productivity costs. 3 Traditional rehabilitation is one of the therapeutic tools to augment the poststroke recovery process. There remains considerable scope for improvement in access to postacute stroke care and continued evolution in response to patient and caregiver needs and the changing environment of healthcare provision.
Although traditional rehabilitation medicine helps patients, a better understanding of its scientific basis could further increase its impact. 17 The characteristics of the rtPA group that increase the likelihood of favorable disposition will be the subject of future studies, including demographics, medical acuity, comorbid conditions, and poststroke complications. In addition, optimal timing of rtPA therapy within the window needs to be defined to quantify the potency of treatment effect on discharge disposition. 
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